Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...
Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel ...
Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...
Basilea Pharmaceutica has entered into a strategic collaboration with Prokaryotics to develop a first-in-class broad-spectrum antifungal therapy targeting severe invasive fungal infections. The ...
Drugs that act against bacteria are mainly assessed based on how well they inhibit bacterial growth under laboratory ...
Scientists have uncovered a new explanation for how swimming bacteria change direction, providing fresh insight into one of ...
News-Medical.Net on MSN
New antibody mechanisms disrupt bacterial adhesion in urinary tract infections
Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...
Certain antibodies employ unusual tactics to keep germs from attaching to cells in our bodies. Their defensive strategies ...
News-Medical.Net on MSN
Active mechanical forces drive how bacteria switch swimming direction
Scientists have uncovered a new explanation for how swimming bacteria change direction, providing fresh insight into one of ...
Drugs that limit the activity of cells called neutrophils could make heart attacks less severe without compromising the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback